Threshold Pharmaceuticals Receives Two U.S. Patents for Tarloxotinib Bromide
October 13, 2015 at 07:02 AM EDT
Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that the U.S. Patent and Trademark Office (USPTO) has issued the first ...